Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected]
- PMID: 24711208
- DOI: 10.1007/s12017-014-8301-2
Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected]
Erratum in
- Neuromolecular Med. 2014 Sep;16(3):643
Abstract
Environmental factors greatly contribute to the development of complex trait disorders. With the rapid developments in the fields of biotechnology and informatics, the investigations of molecular interactions between host and environmental factors became very detailed and comprehensive. The effects of ultraviolet irradiation, vitamin D synthesis, and receptor binding, and then the involvements of the ligand-receptor complexes in the regulation of cell function received much attention in the last few years and paralleled the accumulation of information concerning genetic determinants of disease susceptibility, transcriptional regulation, cell cycle, mitochondrial biochemistry, and many other elements of cell biology. The importance of vitamin D in contributing to immune regulation, autoimmunity, and susceptibility to multiple sclerosis (MS) is now also recognized, and there are ongoing treatment trials with vitamin D to define whether it is capable of modifying susceptibility to or the course of the disease. This survey aims to capture that part of vitamin D research that helps to better understand the interactions of this molecule and its receptor with the human genome, and the downstream effects of these interactions relevant to immune homeostasis and MS. This relatively narrow scope reveals a very complex molecular network underlying inflammatory demyelination and allows us to hope that a better understanding of the roles of vitamin D and other environmental factors will once make the risk of MS modifiable or, to some degrees, the disease preventable.
Similar articles
-
Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.Front Immunol. 2018 Mar 12;9:477. doi: 10.3389/fimmu.2018.00477. eCollection 2018. Front Immunol. 2018. PMID: 29593729 Free PMC article. Review.
-
Vitamin D-gene interactions in multiple sclerosis.J Neurol Sci. 2011 Dec 15;311(1-2):32-6. doi: 10.1016/j.jns.2011.08.041. Epub 2011 Oct 13. J Neurol Sci. 2011. PMID: 22000399 Review.
-
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.Mult Scler. 2013 Jul;19(8):1035-45. doi: 10.1177/1352458512471873. Epub 2013 Feb 11. Mult Scler. 2013. PMID: 23401126
-
[Vitamin D in Multiple Sclerosis].Brain Nerve. 2015 Nov;67(11):1429-33. doi: 10.11477/mf.1416200316. Brain Nerve. 2015. PMID: 26560958 Review. Japanese.
-
Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.J Neurol Sci. 2011 Jun 15;305(1-2):116-20. doi: 10.1016/j.jns.2011.02.032. Epub 2011 Mar 26. J Neurol Sci. 2011. PMID: 21440908
Cited by
-
Vitamin D Receptor Polymorphisms Among the Turkish Population are Associated with Multiple Sclerosis.Balkan J Med Genet. 2023 Mar 1;25(1):41-50. doi: 10.2478/bjmg-2022-0003. eCollection 2022 Jun. Balkan J Med Genet. 2023. PMID: 36880035 Free PMC article.
-
A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis.J Mol Neurosci. 2016 Dec;60(4):498-508. doi: 10.1007/s12031-016-0834-4. Epub 2016 Sep 19. J Mol Neurosci. 2016. PMID: 27647308
-
Nutritional Modulation of Gene Expression: Might This be of Benefit to Individuals with Crohn's Disease?Front Immunol. 2015 Sep 11;6:467. doi: 10.3389/fimmu.2015.00467. eCollection 2015. Front Immunol. 2015. PMID: 26441972 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical